Paul J. Schmitt

Directeur/Membre du Conseil chez Gel Med Sciences, Inc.

Profil

Mr. Paul J.
Schmitt is a Member-Managers Board at JBS United Animal Health II LLC, a Member-Managers Board at Penn State Research Foundation and a Partner at Novitas Capital III LP.
He is on the Board of Directors at Cernostics, Inc., Bellrock Intelligence, Inc., Gel Med Sciences, Inc. and The Wistar Institute.
Mr. Schmitt was previously employed as a Chief Executive Officer by Amorcyte, Inc., an Independent Director by TetraLogic Pharmaceuticals Corp., a Managing Director by Novitas Capital, a Chairman, President & Chief Executive Officer by Chrysalis International Corp., a President by Nextran, a President by Biolectron, Inc., a Founding Trustee by Biotechnology Council of New Jersey, Inc., and a Vice President & General Manager by Datex-Ohmeda, Inc. He also served on the board at Logical Therapeutics, Inc., Encorium Group, Inc., Acelerate, Inc., Agile Therapeutics, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Lehigh University and an MBA from Rutgers State University of New Jersey.

Postes actifs de Paul J. Schmitt

Sociétés	Poste	Début
Gel Med Sciences, Inc.	Directeur/Membre du Conseil	01/01/2000
The Wistar Institute	Directeur/Membre du Conseil	-
JBS United Animal Health II LLC	Corporate Officer/Principal	01/08/2013
Novitas Capital III LP	Corporate Officer/Principal	-
Penn State Research Foundation	Corporate Officer/Principal	-
Bellrock Intelligence, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Paul J. Schmitt

Sociétés	Poste	Fin
Novitas Capital Management LLC	Private Equity Investor	01/08/2018
Encorium Group, Inc.	Directeur/Membre du Conseil	16/07/2008
Chrysalis International Corp.	Directeur Général	31/12/1998
░░░░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░	░░░░░░░░░	-